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 Malaria and Schistosomiasis are the major endemic para-
sitic diseases in the world. The former is killing over one 
million children in Africa per year, and the latter suffers 
several millions in the endemic areas in Asia, Africa and 
South America. 
 Collaborative studies were performed to identify some ge-
netic factors contributing to the development of fatal
forms　 of　 these　 infectious　 diseases.　 In　 Thailand,　 TNF-α 　 5'-
flanking region showed biallelic polymorphic sites at -238, 
-308, -857, -863, -1031, and there were 7 alleles found in 
the patients from Myanmar. We found that the TNFP-D al-
lele was significantly associated with cerebral malaria in 
the populations from Karen (Pc <0.0001, OR=124.86) and 
Burma (Pc <0.0001, OR = 34.50). In China, we have identi-
fied two major genes related to severity of liver fibrosis, 
one was HLA-class II and the other was IL-13 gene. The al-
lele frequencies of HLA-DRB5*0101 and IL-13 promoter 
A/A homozygote were both increased in the fibrotic group 
although the two genes are located in the different chro-
mosomes, Chromosome 6p and 5q. The person who had both 
genotypes showed much higher Odds Ratio (OR=24.5) com-
pared with sum of either genotype positive persons (OR=5.1 
for HLA-DRB5*0101, OR=3.7 for IL-13P A/A). The observa-
tion that the effect of the two susceptible markers were 
synergistic rather than additive, strongly suggested that 
the pathogenic Th2 response directly influence the progno-
sis of post-Schistosomal liver fibrosis. 
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Introduction
 Here I will introduce our recent findings that clearly 
indicated the presence of genetic factors that predict 
the prognosis of two major parasitic infectious dis-
eases, Falciparum malaria and Schistosomiasis japon-
ica. The reason why we were interested in those dis-
eases was that those two diseases provoke serious 
sequelae namely cerebral malaria and post-
schistosomal liver cirrhosis. People in the endemic 
areas are suffering those two forms of complications 
even now. The identification of susceptible or resis-
tant genes to the severe forms is not only useful for 
the prediction of the prognosis but also for under-
standing the pathogenesis and the new treatment. 
 To identify the responsible genes, generally two dif-
ferent approaches are undertaken. One is targeted 
genes analysis and the other is genome wide survey. 
We adopted the former one, especially focused on the 
immune related genes such as HLA, cytokines, and ad-
hesion molecules genes. HLA genes are well known to 
be highly polymorphic and their alleles are well iden-
tified by the DNA sequence levels. For example, HLA-
DRB 1 gene has over 100 alleles in the human popula-
tion. Especially, HLA-DR, DQ, DP, A, B and C are 
believed to be functioning immune response genes to 
exogenous pathogens. Cytokines are also believed to 
play important roles to control the intensity and dura-
tion of the immune response. Recently, single nucleo-
tide polymorphisms (SNPs) are much more frequently 
observed in the promoter regions of some cytokines 
such as TNF, IL-4, IL-13, Interferon-gamma, etc. 
Several studies indicated those polymorphisms di-
rectly affect its promoter activity. 
 We had serious and enthusiastic collaborators in the 
endemic areas and initiated those difficult but very in-
teresting studies several years ago. Finally, we found 
surprisingly strong associations between those mark-
ers and the diseases.
TNF- a Promoter region polymorphism and 
cerebral malaria
 The most severe complication of Plasmodium 
falciparum infection is cerebral malaria (CM) (1). Little 
is known about the pathogenesis of this condition (2). 
Postmortem examination of the affected brain shows a 
typical microembolism, commonly called a sequestra-
tion, which consists of infected red blood cells in cap-
illaries in the brain mesenchyma (3). Therefore, se-
questration is considered to be one of the major 
sequelae causing the typical neurological disturbances 
that occur in CM. Because the serum level of TNF- a 
is reported to be elevated in severe malaria (4), exces-
sive production of TNF- a is suspected to produce 
conditions optimal for sequestration in capillaries (5, 
6). 
 We performed a case control study of CM patients 
in Myanmar to analyze their HLA and TNF- a pro-
moter polymorphisms. A total of 245 unrelated ma-
laria patients, consisting of 145 Karen and 100 
Burmese ethnic groups, were randomly selected. The 
patients were assessed by WHO criteria (7) to be un-
complicated or to have CM at the Mae Sot Malaria 
Clinic or at the Mae Sot General Hospital. 
 The 5'-flanking region of TNF- a , 1,042-bp DNA 
fragment spanning the 5'-flanking region of the TNF-
a gene from position -66 to -1,107 was amplified by 
PCR. After hybridization, 7 possible combinations of 
polymorphic sites in the TNF- a promoter (TNFP) 
were determined in the present study population, giv-
ing TNFP alleles A, B, C, D, M1, M4, and M7. PCR 
products from each tentative genotype were cloned 
and were sequenced to confirm the alleles. The DNA 
typing of HLA-DRB 1 gene was performed by the PCR-
SSOP method used in the Xlth HLA workshop (8). 
HLA-B DNA typing was performed as previously de-
scribed (9).
Table 1. TNF- a 5'-flanking region alleles detected in the 
Myanmar patients with malaria.
            Polymorphic sites of the promoter region of TNF- a gene 
                   -238 -308 -857 -863 -1031
TNFP-A G G C C T 
TNFP-B G G C A C 
TNFP-C A G C C C 
TNFP-D G G T C T
Footnote for Table 1. 
The TNFP-A, B, C, D types are reported by Higuchi et al. 
(10).
Table 2. Genotype frequency of the 5'-flanking region of 
TNF- a gene in Myanmar CM and uncomplicated patients.
                       Burmese Karen 
              Uncomplicated CM Uncomplicated CM 
  Genotype n=94 (%) n=21 (%) n=106 (%) n=22 (%) 
TNFP-D -/- 92 (97.9) 12 (57.1) 106 (100) 14 (63.6) 
     +/+ and+/- 2 (2.1) 9 (42.9) ~ 0 (0.0) 8(36.4)--
Footnote for Table 2. 
* Pc<0 .001, OR=34.50, 95%CI: 6.65 - 178.98. 
** Pc<0 .001, OR=124.86, 95%CI: 6.84 - 2279.51,
 Table 1 shows 7 alleles detected in the present 
study. The TNFP-A, B, C, D alleles were exactly the 
same types as were reported in the previous study 
from the Japanese population (10,11). The remaining 
three alleles, TNFP-M1, M4, and M7 were novel types 
that have not been reported elsewhere. Table 2 shows 
the allele frequencies of TNF- a promoter region in 
patients with CM and in uncomplicated patients from 
Karen and Burma. The occurrence of the TNFP-D +/+ 
and +/- genotypes were significantly increased in pa-
tients with CM in both ethnic groups. 
 This is the first study that reports the positive asso-
ciation of the TNFP-D allele with CM. The first report 
that there was a relationship between TNF- a pro-
moter polymorphism and CM was published by 
McGuire, et al. restriction enzyme Nco 1 polymorphism 
(-308A/G) was used to show that the TNF2 (-308A) al-
lele was associated with CM in Gambian school chil-
dren. The position -576 polymorphic site where the 
nuclear factor OCT-1 binds, was reported to be associ-
ated with CM in the same Gambian population (13). 
We have also checked this region using specific probes 
and sequencing but have found no polymorphisms in 
the Myanmar subjects. 
 The TNFP-D allele that we found to be strongly as-
sociated with CM in Myanmar was reported to be a 
high expresser of TNF- a compared with the TNFP-B 
or C alleles in studies of peripheral blood mononuclear 
cells (PBMCs) stimulated with Concanavalin A in 
vitro, and by luciferase assays with the Raji cell 
transfection system (10). Skoog, et. al. (11) reported 
that in the TNFP-B allele the Nf- K B binding motif is 
broken by the substitution of -863C to A. This allele 
is common in Myanmar but is rare in Sweden (11) 
and the mutation results in reduced promoter activity. 
Serum level of TNF- a was lower in the healthy vol-
unteers who were homozygous for this mutant type in 
Sweden (11). Though there is little information
available, when we compared the gene frequencies of 
the TNFP alleles in different ethnic groups, we found 
that the gene frequencies of the -863C or -1031T al-
leles, both typical for TNFP-D, were much higher in 
Sweden (0.94 for -863C, 0.80 for -1031T) (19) and in 
Japan (0.82 for -863C, 0.84 for -1031T) (9) than in the 
Myanmar patients (0.08 for -863C, 0.15 for -1031T). It 
would be of interest to see the frequencies of those al-
leles in African populations. It is possible to generate 
such a difference by natural selection.
HLA-class II genes and IL-13 promoter region 
polymorphism and Schistosomal liver fibrosis
 Schistosomiasis japonica (S. japonica) is a chronic 
helminthic infectious disease that affected at least 
860,000 individuals in China in 1995. Morbidity and 
mortality are dependent on its chronic sequelae, post-
schistosomal hepatosplenic disease, which is character-
ized by liver fibrosis, portal hypertension, ascites accu-
mulation, esophageal varices, and eventual death 
(Figure 1). The liver fibrosis seen in these patients is 
provoked by a granulomatous immune response 
against the eggs that are deposited in the periportal 
area (14). Schistosomal egg antigen-specific CD4+ T 
cells play a major role in the formation of granuloma 
through Th2 type cytokine production in experimen-
tal schistosomiasis mansoni (15,16). However, in hu-
mans, little is known about immunology on the 
chronic phase of hepatosplenic disease (17). Because 
only 5-10 percent of the chronic patients with S. ja-
ponica develop hepatosplenic disease and because 
granulomatous response is derived from CD4+ T cells 
reactive to Schistosomal antigen, HLA-class II poly-
morphism, which controls the reactivity of the CD4+ T 
cells, possibly relates to susceptibility to hepatosplenic 
disease. Indeed, associations of schistosomal 
hepatosplenic disease with HLA alleles have been re-
ported in S. mansoni (18) and in S. japonica (19,20).
Figure 1. Life cycle of Schistosoma japonicum.
Recently, more objective diagnostic methods using 
ultrasonography have become popular and standard-
ized to measure the changes in liver morphology (21). 
Therefore, we used this method to categorize the pa-
tients into fibrotic group and no fibrotic group and 
observed their genetic features by the analyses of 
polymorphism of candidate genes encoding HLA-class 
II, classl, TNF, and cytokines. 
 A total of 230 current or former patients with 
chronic schistosomiasis japonica were examined for 
liver changes. All patients were from the agricultural 
village, Beishan, in Yushan county, China, and had 
their first episode of infection and treatment at least 
10 years before this study began. The mean age of 
the subjects was 52.6 ± 10.5 years and the mean dura-
tion after their initial treatment was 27.4 ± 8.8 years. 
The ultrasonographic diagnosis was carried out ac-
cording to the World Health Organization standard for 
the diagnosis of liver fibrosis due to schistosomiasis 
japonica (21, 22, 23) (Figure 2). Ultrasonographic diag-
nosis determined that there were 44 persons with 
grade 0, 81 with grade I, 99 with grade II, and 6 with 
grade III fibrosis. The presence of Hepatitis B virus 
(HBV) was not examined in these patients, but the 
prevalence of HBV positives is about 15 % in the 
Jiangxi province (24). Most of the men in the village 
smoke tobacco and drink alcoholic beverages, but the 
women generally do not. The patients had all been
C
Figure 2. Dignosis of post-schistosomal liver fibrosis and cir-
rhosis by Ultrasonography. 
 A; Grade 0. B; Grade I. C; Grade II. 
 D; Grade III. Showing the fish scale pattern.
Grade 0 n=36 Grade 1,11,111 n=156
Table 3. Synergistic effect of the two susceptible markers, 
HLA-DRB5*0101 and IL-13P*A/A.





DRB5* IL-13P n=36 (%) n=156 (%) P value* OR* (95%cl)* 
0101 A/A 0 (0.0) 21 (13.4) p<0.01 24.49 (1.41 - 424 .0) 
0101 - 2 (5.6) 18 (11.5) p<0.05 5.08 (1.08 - 23.9) 
- A/A 12 (33.3) 78 (49.7) p<0.05 3.67 (1.64 - 8.17) 
           22 (61.1) 39 (25.0)
Footnote for Table 3. 
* P value , OR and 95%CI were calculated against individuals 
 negative for both DRB5*0101 and IL-13P* A/A
Figure 3. Associations of HLA-DRB5*0101 and IL-13P*A/A 
with fibrotic group of chronic Schistosomiasis.
treated with praziquantel for each positive fecal ex-
amination throughout their lives, but the precise total 
worm burden of each patient during their clinical 
course was not available. Therefore, we tentatively 
defined a person who had a record of repeated treat-
ments for S. japonica over a ten-year period as an ap-
propriately exposed person (22). 
 In total, 29 alleles for HLA-DRB1, 3 for HLA-DRB3, 
2 for HLA-DRB5, 13 for HLA-DQA1, 11 for HLA-
DQB1, 4 for HLA-DPA1, 18 for HLA-DPB1, and 24 al-
leles for HLA-B were detected in this population. No 
significant change occurred in the frequency of the 
HLA-B types in the two different severities of fibrosis. 
On the contrary, the frequencies of several HLA-class 
II alleles significantly increased or decreased in the 
fibrotic groups. When we compared the frequencies 
of alleles between grade 0 and grades I, II, and III, we 
found that HLA-DRB 1 * 1101 (Pc < 0.001), DQA 1 *0501 
(Pc < 0.02), and DQB1*0301 (Pc < 0.03), which are 
closely linked, significantly increased in grade 0 and 
that HLA-DRB5*0101 significantly increased in grade 
I, II, and III fibrotic patients (Pc < 0.03) (Figure 3). 
This suggests that the HLA-DRB 1 * 1101-DQB 1 *0301-
DQA 1 *0501 haplotype (Pc < 0.02) decreases while the 
HLA-DRB1*1501-DRB5*0101 haplotype (Pc < 0.02) in-
creases the susceptibility to grades I, II, and III fibro-
sis. If we assume that these gene associations are de-
rived from the function of HLA molecules themselves, 
then the critical question is how do these molecules 
present the antigens to CD4+ T cells for initiation of 
the immunological process leading to fibrosis. So far 
we have not yet identified the responsible antigen(s) 
for the stimulation of pathogenic or protective T cells 
through such HLA-molecules. 
 For the same subjects, we have analysed their
Figure 4. Synergistic effect of two susceptible markers sug-
gests the presence of pathogenic CD4 T cells in the liver.
polymorphism of Th2 cytokine genes. Within those, 
significant association was observed between IL-13 
promoter SNPs allele homozygote and liver fibrosis 
group as shown in Figure 3. Because the IL-13 gene is 
localized on the long arm of Chromosome 5, IL-13 pro-
moter allele must be independent from HLA-class II 
allele that is on the short arm of chromosome 6. So 
the next question was whether there is any interac-
tion between those two genetic markers, HLA and IL-
13. As shown in Table 3, both HLA-DRB5*0101 and 
IL-13P*A/A positive persons showed much higher 
Odds Ratio (24.5) than either positive groups (5.1 for 
HLA, 3.7 for IL-13P*A/A) indicating those two genetic 
markers synergistically enhanced the development of 
fibrosis after infection. This synergy is well explained 
by the cartoon of Figure 4 showing that the patho-
genic IL-13 producing CD4 T cells are preferentially 
stimulated by the antigen presenting cells bearing 
HLA-DRB5*0101. Further study will be needed to 
show that this cartoon is not just the cartoon.
Conclusion
 TNF- a promoter allele profoundly influenced the 
prognosis of cerebral malaria in the adult patients in 
Myanmar. Synergistic effect of two susceptible mark-
ers, HLA-DR and IL-13 promoter alleles, was clearly 
shown in the development of liver fibrosis of the 
chronic patients with Schistosoma japonicum in 
China.
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